about
Chronic cocaine-regulated epigenomic changes in mouse nucleus accumbens.MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1Role of RNA structure in regulating pre-mRNA splicingArthrogryposis: a review and updateElevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophyThe importance of CELF control: molecular and biological roles of the CUG-BP, Elav-like family of RNA-binding proteinsRNA-Binding Proteins: Splicing Factors and DiseaseStructural studies of CNG repeatsThe multiple molecular facets of fragile X-associated tremor/ataxia syndromeRNA-mediated neurodegeneration in fragile X-associated tremor/ataxia syndromeTriplet repeat-derived siRNAs enhance RNA-mediated toxicity in a Drosophila model for myotonic dystrophyStructural insights into RNA recognition by the alternative-splicing regulator muscleblind-like MBNL1Structural insights into CUG repeats containing the 'stretched U-U wobble': implications for myotonic dystrophyStructural Insights into RNA Recognition by the Alternate-Splicing Regulator CUG-Binding Protein 1Utilizing the GAAA Tetraloop/Receptor To Facilitate Crystal Packing and Determination of the Structure of a CUG RNA HelixStructural dynamics of double-helical RNAs composed of CUG/CUG- and CUG/CGG-repeatsDefining potentially conserved RNA regulons of homologous zinc-finger RNA-binding proteinsDrosophila as an In Vivo Model for Human Neurodegenerative DiseaseIdentification of variants in MBNL1 in patients with a myotonic dystrophy-like phenotypeAlternative splicing of myomesin 1 gene is aberrantly regulated in myotonic dystrophy type 1The regulatory element in the 3'-untranslated region of human papillomavirus 16 inhibits expression by binding CUG-binding protein 1RNA toxicity is a component of ataxin-3 degeneration in DrosophilaGenetic and chemical modifiers of a CUG toxicity model in DrosophilaA postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heartPolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeatsApproaches to Validate and Manipulate RNA Targets with Small Molecules in CellsEukaryotic stress granules: the ins and outs of translationNKX2-5, a modifier of skeletal muscle pathology due to RNA toxicity.Biological Efficacy and Toxicity of Diamidines in Myotonic Dystrophy Type 1 Models.The RNA-binding protein Staufen1 is increased in DM1 skeletal muscle and promotes alternative pre-mRNA splicingTherapeutics development in myotonic dystrophy type 1.New function for the RNA helicase p68/DDX5 as a modifier of MBNL1 activity on expanded CUG repeatsExpanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophyUltrasound-enhanced delivery of morpholino with Bubble liposomes ameliorates the myotonia of myotonic dystrophy model micePKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1.Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations.CTG trinucleotide repeat "big jumps": large expansions, small miceRepeat length and RNA expression level are not primary determinants in CUG expansion toxicity in Drosophila modelsDrosophila muscleblind is involved in troponin T alternative splicing and apoptosisRNA gain-of-function in spinocerebellar ataxia type 8.
P2860
Q21999524-1193AC04-79AD-4CCF-B93F-6248555EE990Q24311381-C0865EF1-CBFC-43F1-B63A-C3D3FF8C764DQ24631714-5D0CC7BD-607E-4303-9C30-10EC1D074E0DQ24644127-CC178EE3-9760-4B0B-B639-807A2765E931Q24670706-ABC129EA-203C-4E3D-96EF-7DB1AE7C4227Q26823119-FEB69FF4-84F0-4193-B8DD-6225D68CD7DCQ26823957-9B902E92-CD0B-47F7-B8A4-2607EBF98C3AQ26851232-B4E8079E-676C-43AB-A585-8D47092DC894Q26852891-55A3E7DF-C269-4159-A742-6D1ECB30E2A5Q26992035-1249C5AD-3CC6-4CEE-B8E0-0736447EC016Q27342852-CDBC28CD-0D88-46DF-8D10-17A540C7874BQ27653016-F984CE81-B02E-4DB8-8209-6287D0E6FC5DQ27655444-1C25FA68-6BD4-4670-AEC7-0686552BF943Q27665048-8A735C6B-B77F-4350-9990-22F911AB2A0BQ27673782-21873563-B198-41D2-8F7C-B3CE913A0213Q27681374-61CFA8CE-9CFF-4059-915F-A1D89C5DC933Q27933208-8FD0896A-6291-4116-BE5D-B60110C3E251Q28088777-FC3B1D17-85A0-4666-925A-7B4B11B68D39Q28115791-F14A6D70-AACD-4200-B8F3-3A53AC2F62B6Q28244232-86D6F8FA-DB73-4069-9CD9-3D320DFCCDC7Q28258910-43D1D477-ED53-4C6F-9A53-3EE0AEFE6E01Q28278448-347246A1-96FC-4FA6-8DCF-B86F6FFD0A2CQ28472129-FB0B4693-D4DF-48CC-BBAA-09C46EBA77A0Q28593731-C27174E2-732D-4E8B-A47C-DE865CF7EBF1Q28741564-55A1BEEE-E8BA-4340-9EB1-B5547EC69E0FQ28833658-E3A3B4C1-C506-42A0-A79B-4CEB86BFCDA7Q29619569-31E620DC-F905-4C96-93DC-8C106A8B66F5Q30361778-3A7F2575-AF76-4B70-A172-5622D4DFAEE7Q30377390-96F69729-0BE1-45B6-AF69-F8ED189B09C2Q30424920-B883D341-3608-4ECB-A01A-E513694C5654Q30425796-B83E7158-79E8-4A76-8A1A-8F9B4F5FD75DQ30427374-C283135A-08AE-4DE3-AAF3-085C42F3AA59Q30441256-C7FC16DF-69FD-4837-B6A5-EF248A548FBCQ30452003-50024BDF-E893-4421-B8FB-BB5A01506C31Q30492100-0FF2F697-B3CC-4E97-AD49-A4A17598B0D7Q30498672-E321F030-9DC0-43CE-849C-F853BB9AA1EEQ33281292-2E0B71CB-0498-4EAD-B166-D5E7F1F923A0Q33316025-79974BCB-C5BD-406A-8AD9-23A3F0B5B850Q33320523-B9B533E5-A086-4FE9-96A7-D96AC36E8D48Q33493406-E3B92AD8-862A-423E-8A5A-2831C2BED46E
P2860
description
2006 nî lūn-bûn
@nan
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
name
RNA-mediated neuromuscular disorders.
@ast
RNA-mediated neuromuscular disorders.
@en
type
label
RNA-mediated neuromuscular disorders.
@ast
RNA-mediated neuromuscular disorders.
@en
prefLabel
RNA-mediated neuromuscular disorders.
@ast
RNA-mediated neuromuscular disorders.
@en
P1476
RNA-mediated neuromuscular disorders.
@en
P2093
Laura P W Ranum
Thomas A Cooper
P304
P356
10.1146/ANNUREV.NEURO.29.051605.113014
P577
2006-01-01T00:00:00Z